HNWAG
XBIT icon

High Net Worth Advisory Group’s XBiotech XBIT Stock Holding History

High Net Worth Advisory Group’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,500
Closed -$13K – 729
2022
Q1 		$13K Hold
1,500
– – ﹤0.01% 504
2021
Q4 		$17K Buy
+1,500
New +$19.5K 0.01% 487

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

High Net Worth Advisory Group's XBIT Position: Q2 2022 in Review

High Net Worth Advisory Group sold out of XBiotech (XBIT) in Q2 2022, closing a stake of 1,500 shares — an estimated $13K sold.

High Net Worth Advisory Group first reported a position in XBIT in Q4 2021 and held it in 2 quarters. The position peaked at $17K in Q4 2021. 56 funds tracked by Wall St. Rank hold XBIT as of Q2 2022.

  • High Net Worth Advisory Group reported no remaining XBiotech position as of Q2 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 1,500 XBiotech shares in Q2 2022, an estimated $13K.
  • High Net Worth Advisory Group first reported a position in XBiotech in Q4 2021 and held it in 2 quarters.
  • High Net Worth Advisory Group's XBiotech position peaked at $17K in Q4 2021.
  • 56 funds tracked by Wall St. Rank held XBiotech as of Q2 2022.

Based on High Net Worth Advisory Group's 13F filing for Q2 2022, filed 10 Aug 2022.